Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Inactivated Influenza Vaccine”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT02585700
What this trial is testing

A Seasonal Trivalent Split, Inactivated Influenza Vaccine

Who this might be right for
Influenza, Human
Institute of Virology, Vaccines and Sera, Torlak 60
Testing effectiveness (Phase 2)Study completedNCT03589807
What this trial is testing

2013/2017 H7N9 Prime-Boost Interval

Who this might be right for
Avian InfluenzaInfluenza Immunisation
National Institute of Allergy and Infectious Diseases (NIAID) 180
Testing effectiveness (Phase 2)Study completedNCT00908687
What this trial is testing

A/H5N1/LT Dose Ranging Study

Who this might be right for
Pandemic Influenza
Intercell USA, Inc. 500
Post-approval studies (Phase 4)Study completedNCT01427309
What this trial is testing

Fluzone® High-Dose Vaccine Compared With Fluzone® Vaccine In Elderly Adults

Who this might be right for
Influenza
Sanofi Pasteur, a Sanofi Company 31,989
Not applicableLooking for participantsNCT06029933
What this trial is testing

Fluad vs. Fluzone High-Dose Vaccine Effectiveness Among Adults ≥65 Years

Who this might be right for
InfluenzaCommunity-acquired PneumoniaCardiovascular Events
Kaiser Permanente 1,500,000
Testing effectiveness (Phase 2)Study completedNCT00316615
What this trial is testing

Safety and Immunogenicity of a Inactivated Influenza Vaccine When Administered to Non Elderly Adults and Elderly Subjects.

Who this might be right for
Influenza Disease
Novartis 100
Not applicableStudy completedNCT01032980
What this trial is testing

Post Authorization Safety Study of the Pandemic A/H1N1 Influenza Vaccines in Children and Adults

Who this might be right for
InfluenzaSwine-Origin A/H1N1 Influenza Virus
Sanofi Pasteur, a Sanofi Company 3,934
Post-approval studies (Phase 4)Ended earlyNCT03328325
What this trial is testing

Age and Response to Flu Vaccines

Who this might be right for
InfluenzaInfluenza Immunisation
National Institute of Allergy and Infectious Diseases (NIAID) 152
Large-scale testing (Phase 3)Study completedNCT00354016
What this trial is testing

Safety and Immunogenicity of Preservative Free Inactivated Split Influenza Vaccine, Using the Strain Composition 2006/2007 in Non-Elderly Adult and Elderly Subjects

Who this might be right for
Influenza
Novartis 125
Early research (Phase 1)Study completedNCT00848887
What this trial is testing

A Dose Ranging Study Comparing Different Combinations of Adjuvanted and Non-adjuvanted Influenza Vaccines in Healthy Children 6 to <36 Months of Age

Who this might be right for
Influenza
Novartis 410
Testing effectiveness (Phase 2)Study completedNCT01086904
What this trial is testing

Safety and Efficacy of an Inactivated and Non Adjuvanted Vaccine Against Influenza A in Renal Transplant Recipients

Who this might be right for
Renal Transplant RecipientsImmunosuppression
Institut National de la Santé Et de la Recherche Médicale, France 122
Large-scale testing (Phase 3)Study completedNCT00800605
What this trial is testing

Immunogenicity Study of an Inactivated Influenza Vaccine (Split Virus, Vero Cell Derived) to Prevent Culture Confirmed Influenza Infection

Who this might be right for
Influenza
Alachua Government Services, Inc. 7,250
Post-approval studies (Phase 4)Study completedNCT02783170
What this trial is testing

Safety and Immunogenicity of Simultaneous Tdap and IIV in Pregnant Women

Who this might be right for
Pregnancy
Duke University 81
Early research (Phase 1)Study completedNCT02957656
What this trial is testing

Safety and Immunogenicity of Priming With Live Attenuated A/H7N9 Influenza Virus Vaccine Followed By Inactivated A/H7N9 Influenza Virus Vaccine With AS03 Adjuvant

Who this might be right for
Influenza A Virus, H7N9 Subtype
National Institute of Allergy and Infectious Diseases (NIAID) 53
Testing effectiveness (Phase 2)Study completedNCT00703651
What this trial is testing

Study of Inactivated, Split-Virion Influenza Vaccine Administered by Intradermal Route Versus Vaxigrip® in Adults

Who this might be right for
InfluenzaOrthomyxoviridae InfectionMyxovirus Infection
Sanofi Pasteur, a Sanofi Company 1,150
Large-scale testing (Phase 3)Study completedNCT02467842
What this trial is testing

Immunogenicity and Safety of Quadrivalent Influenza Vaccine (NBP607-QIV) in Adults and Elderly Subjects

Who this might be right for
Influenza
SK Chemicals Co., Ltd. 1,503
Post-approval studies (Phase 4)Study completedNCT04790851
What this trial is testing

Evaluation of Immunogenicity and Safety of Combined Immunization of COVID-19 Vaccine (Produced in Beijing) and PPV23 / IIV4

Who this might be right for
Influenza, HumanPneumonia, PneumococcalCovid19
China National Biotec Group Company Limited 1,133
Large-scale testing (Phase 3)Study completedNCT03020628
What this trial is testing

Immunogenicity and Safety of Quadrivalent Influenza Vaccine in Children Aged 6~35 Months

Who this might be right for
Influenza, Human
SK Chemicals Co., Ltd. 171
Large-scale testing (Phase 3)Study completedNCT00333398
What this trial is testing

Immunogenicity, Safety and Tolerability of CSL Limited Inactivated Influenza Vaccine in Adults

Who this might be right for
Influenza
National Institute of Allergy and Infectious Diseases (NIAID) 1,359
Post-approval studies (Phase 4)Study completedNCT01246999
What this trial is testing

Effect of Age and Prior Immunity to Response to Seasonal Influenza Vaccines in Children

Who this might be right for
Influenza
University of Rochester 34
Next Page